# A promising cure for PTSD: Cannabis-based medicine suppresses aversive memory and eases anxiety > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-based-medicine-ptsd-anxiety-relief/ > **Published:** 2021-06-08T15:26:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:17:06-04:00 > **Clinical Summary:** Explore how cannabis-based medicine PTSD treatments suppress aversive memory and ease anxiety, offering new hope for managing symptoms effectively. --- ### Effects of Δ9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies In Summary: ​ Post traumatic stress disorder (PTSD) is a mental disorder that arises after a person experiences or witnesses a terrifying event. Its symptoms include nightmares or invasive memories of the trauma, excessive avoidance of situations that bring back these memories, heightened reactions, anxiety, or depressed mood and can last for months or years. Some PTSD patients have recreationally used cannabis to ease their symptoms. However, whether and how cannabis or its main psychologically active component, Δ9-tetrahydrocannabinol (THC) attenuates the aversive, traumatic memory and associated anxiety remained largely unknown until very recently. In the first large-scaled review of effects of THC on aversive memory and anxiety in PTSD patients, researchers found evidence that THC, dronabinol (the synthetic form of THC), and nabilone (a synthetic analog of THC) indeed help alleviate anxiety, insomnia, and over-generalized, heightened arousal as well as facilitate fear memory extinction when used at low doses. Additionally, at such dose, these compounds also don’t induce a psychotic effect. However, high doses of these substances don’t have the same benefit while causing psychotic symptoms. The scientists also noted that most currently available [clinical studies](https://cedclinic.com/state-licensed-cannabis-research-frameworks-missouri/) evaluated the [acute effects](https://cedclinic.com/episodic-memory-cannabis-impairment-study/) of THC only, and we lack data on whether chronic treatment with cannabis-derived medicine is still advantageous for PTSD patients. By and large, documented findings do suggest cannabis-derived medicine can aid in extinguishing aversive memory and alleviating associated anxiety, making it a potential candidate for PTSD therapeutic strategy. Still, we should be cautious and seek future studies that address open questions related to its optimal dose and prolonged efficacy. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Redu](https://cedclinic.com/nabilone-synthetic-cannabinoid-ptsd-insomnia-pain/) This article explores synthetic cannabinoids' effects on PTSD-related insomnia and nightmares, providing insights into [alternative treatment](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) options. [Read More](https://cedclinic.com/nabilone-synthetic-cannabinoid-ptsd-insomnia-pain/) [Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) A case series examining cannabidiol's therapeutic potential for PTSD, highlighting [clinical outcomes](https://cedclinic.com/medical-cannabis-product-safety-testing-maine-bill/) and patient experiences. [Explore Study](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) [The endocannabinoid receptor CB2 is a regulator of trauma-inducing anxiety and a potential target for PTSD drugs](https://cedclinic.com/cannabinoid-cb2-receptors-anxiety-ptsd-regulation/) Research on the CB2 receptor's role in anxiety and trauma offers promising directions for PTSD [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/). [Learn More](https://cedclinic.com/cannabinoid-cb2-receptors-anxiety-ptsd-regulation/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=A%20promising%20cure%20for%20PTSD%3A%20Cannabis-based%20medicine%20suppresses%20aversive%20memory%20and%20eases%20anxiety&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-based-medicine-ptsd-anxiety-relief%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-based-medicine-ptsd-anxiety-relief%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=A%20promising%20cure%20for%20PTSD%3A%20Cannabis-based%20medicine%20suppresses%20aversive%20memory%20and%20eases%20anxiety%20https%3A%2F%2Fcedclinic.com%2Fcannabis-based-medicine-ptsd-anxiety-relief%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).